RSS   Newsletter   Contact   Advertise with us
Post Online Media

Symic names Manish Anand as VP, regulatory affairs and quality

Manish AnandSymic, a clinical stage biotherapeutics company, announced the appointment of Manish Anand as vice president of regulatory affairs and quality.
Article continues below

READ MORE Exosome Diagnostics names VP, regulatory affairs and quality

Mr. Anand brings to the company 14 years of industry experience in advancing drug candidates from preclinical stages of development to marketing as well as experience in post­marketing development.

He has had responsibility for interactions with international regulatory agencies including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

Mr. Anand has been involved in the development of drugs, biologics, blood products and vaccine therapies for a diverse range of therapeutic areas such as hematology, oncology, CNS, inflammation and orphan disease.

Prior to joining Symic, Mr. Anand was Director of Regulatory Affairs at Portola Pharmaceuticals. He has also served in regulatory affairs positions at BioMarin, Vanda, MacuSight and Medimmune.

Mr. Anand received a M.S. in Biotechnology from the Johns Hopkins University and a B.S. in Chemistry from Lafayette College.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy